Free Trial

AstraZeneca (AZN) SEC Filings & 10K Form

AstraZeneca logo
$75.99 -1.51 (-1.95%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$76.10 +0.12 (+0.15%)
As of 03/10/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AstraZeneca SEC Filings

DateFilerForm TypeView
03/07/2025
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:17 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:20 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
5:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
10:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2025
9:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
9:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
8:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
5:59 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
9:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
7:02 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
8:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
11:15 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form EFFECT
02/03/2025
12:05 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
5:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
8:25 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
8:52 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
Form SCHEDULE 13D/A
01/21/2025
11:17 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
01/21/2025
5:40 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2025
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
10:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
11:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2024
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
8:01 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:28 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
5:43 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
5:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
8:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
5:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
11:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
6:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
8:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
10:46 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
5:00 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
A deadly mistake in my prediction… (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

10/21/2024
8:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
5:01 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
9:45 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:44 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:27 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
12:34 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
9:50 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
5:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
9:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
8:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
9:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
4:00 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
5:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
9:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
9:02 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
06/03/2024
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
9:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
5:32 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
5:41 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
6:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
5:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
6:18 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
12:22 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
5:55 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
5:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
7:45 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
6:54 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
6:28 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
4:27 PM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
Form DFAN14A
03/19/2024
3:31 PM
AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form F-3ASR
Your Wealth is Under Attack (Ad)

Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.

Click here now to see how to stop them in their tracks!
03/19/2024
5:02 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
6:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
6:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:AZN) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners